These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29268252)
1. Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress. Li XZ; Ding YZ; Wu HF; Bian ZP; Xu JD; Gu CR; Chen XJ; Yang D Cell Physiol Biochem; 2017; 44(6):2422-2438. PubMed ID: 29268252 [TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against the pathological cardiac hypertrophy in mice. Liu ZH; Liu HB; Wang J Biomed Pharmacother; 2018 Jan; 97():1468-1478. PubMed ID: 29793309 [TBL] [Abstract][Full Text] [Related]
3. The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure. Sui YB; Zhang KK; Ren YK; Liu L; Liu Y Pharm Biol; 2020 Dec; 58(1):1192-1198. PubMed ID: 33253607 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation. Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482 [TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels. Hu JY; Han J; Chu ZG; Song HP; Zhang DX; Zhang Q; Huang YS Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):351-7. PubMed ID: 18986331 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress. Lin J; Fang L; Li H; Li Z; Lyu L; Wang H; Xiao J Eur J Pharmacol; 2019 Sep; 859():172490. PubMed ID: 31229536 [TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy. Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369 [TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis. Liu T; Yang F; Liu J; Zhang M; Sun J; Xiao Y; Xiao Z; Niu H; Ma R; Wang Y; Liu X; Dong Y Exp Anim; 2019 Nov; 68(4):549-558. PubMed ID: 31243190 [TBL] [Abstract][Full Text] [Related]
9. Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence. Shi L; Deng J; He J; Zhu F; Jin Y; Zhang X; Ren Y; Du X Eur J Pharmacol; 2024 Jul; 975():176632. PubMed ID: 38718959 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy]. Shi H; Ma C; Liu Y; Zhou J; Hu Z; Wu D Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3242-6. PubMed ID: 20353010 [TBL] [Abstract][Full Text] [Related]
11. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress. Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Ago T; Kuroda J; Pain J; Fu C; Li H; Sadoshima J Circ Res; 2010 Apr; 106(7):1253-64. PubMed ID: 20185797 [TBL] [Abstract][Full Text] [Related]
13. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress. Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997 [TBL] [Abstract][Full Text] [Related]
14. Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice. Wu X; Cao Y; Nie J; Liu H; Lu S; Hu X; Zhu J; Zhao X; Chen J; Chen X; Yang Z; Li X Am J Pathol; 2013 Jun; 182(6):2005-14. PubMed ID: 23567640 [TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV intervenes multi-regulatory cell death forms against doxorubicin-induced cardiotoxicity by regulating AMPKα2 pathway. Hu Y; Yu J; He W; Qiao Y; Cheng X; Huang H; Lai S; Yin D; He H Int Immunopharmacol; 2024 Dec; 142(Pt A):113078. PubMed ID: 39236461 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway. Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress. Zhang C; Wang F; Zhang Y; Kang Y; Wang H; Si M; Su L; Xin X; Xue F; Hao F; Yu L; Xu J; Liu Y; Xue M J Cell Mol Med; 2016 Jan; 20(1):116-27. PubMed ID: 26512452 [TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice. Xu N; Kan P; Yao X; Yang P; Wang J; Xiang L; Zhu Y J Microbiol; 2018 Nov; 56(11):838-846. PubMed ID: 30353470 [TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV protects rat gastric mucosa against aspirin-induced damage. Fan DD; Lin S; Song YP; Wang ZY; Liu B; Gao SN; Fan YH; Zhu S; Li S; Jiang L Int Immunopharmacol; 2016 Dec; 41():47-55. PubMed ID: 27816726 [TBL] [Abstract][Full Text] [Related]
20. Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis. Zhang ZC; Li SJ; Yang YZ; Chen RZ; Ge JB; Chen HZ J Asian Nat Prod Res; 2007 Mar; 9(2):145-51. PubMed ID: 17454311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]